Cardiomyopathy and heart failure

• Clinical management and healthcare resource utilization among patients with obstructive hypertrophic cardiomyopathy in Spain: a real-world study

  Roberto Barriales-Villa, Luis Escobar-López, David Vilanova Larena, Joel Salazar-Mendiguchía, Ainara Echeto, Ignacio Hernández, Elena Rebollo-Gómez, Juan Ramón Gimeno

  Rev Esp Cardiol. 2025;78:1041-53

• Severe primary graft dysfunction after heart transplant: trends and outcomes in a contemporary Spanish cohort

  Carlos Ortiz-Bautista, Luis Almenar-Bonet, David Couto-Mallón, José González-Costello, Javier Segovia-Cubero, Diego Rangel-Sousa, Joan Guzmán-Bofarull, Antonia Pomares-Varó, Juan F. Delgado-Jiménez, Beatriz Díaz-Molina, Iris P. Garrido-Bravo, Teresa Blasco-Peiró, María del Val Groba Marco, Javier Muñiz-García, Francisco González-Vílchez

  Rev Esp Cardiol. 2025;78:1054-63

• Left ventricular ejection fraction decline and cardiovascular events in suspected cardiomyopathy with excessive trabeculation: toward precision medicine

  Guillem Casas, Eduard Ródenas-Alesina, Javier Limeres, Clara Badia-Molins, José M. Larrañaga-Moreira, Jesús G. Mirelis, Javier Navarrete-Navarro, Jesús Martín-Jiménez, Juan E. Alcalá-López, Josefa González-Carrillo, Albert Teis, Rafaela Soler-Fernández, Gisela Teixidó-Turà, Laura Gutiérrez-García, Paula Fernández-Álvarez, Patricia Muñoz-Cabello, José A. Barrabés, Coloma Tirón, Julián Palomino-Doza, José Manuel García-Pinilla, Antoni Bayés-Genís, Tomás Ripoll-Vera, Juan Jiménez-Jáimez, Eduardo Villacorta, Juan Ramón Gimeno-Blanes, Esther Zorio, Pablo García-Pavía, Roberto Barriales-Villa, Andrea Guala, Steffen E. Petersen, Ignacio Ferreira-González, José F. Rodríguez-Palomares

  Rev Esp Cardiol. 2025;78:934-44

• Impact of amyloidosis on outcomes after transcatheter aortic valve implantation

  Luigi Gerra, Tommaso Bucci, Ho Man Lam, Marta Mantovani, Antonios A. Argyris, Muath Alobaida, Kully Sandhu, Joseph Mills, Giuseppe Boriani, Gregory Y.H. Lip

  Rev Esp Cardiol. 2025;78:886-95

• Identification of phenotypes in heart failure with preserved ejection fraction among 8161 patients from 3 Spanish cohorts

  Òscar Miró, Olivier Peyrony, Joan Carles Trullàs, Aitor Alquézar-Arbé, Julio Núñez, Pedro López-Ayala, Javier Jacob, Héctor Bueno, Manuel Montero-Pérez-Barquero, José Carlos Arévalo-Lorido, Rafael de la Espriella, Gema Miñana, Juan Sanchis, Pere Llorens

  Rev Esp Cardiol. 2025;78:896-905

• Hereditary transthyretin amyloidosis caused by the Val142Ile variant in Spain

  Fernando de Frutos, Lorena Herrador, Belén Peiró-Aventín, Rocío Eiros, Javier Limeres Freire, Esther Zorio, Álvaro Carbayo, Pasqual Llongueras-Espí, Ana García-Álvarez, Tomás Ripoll-Vera, Rosa Macías, Silvia Vilches, Sonia Ruiz-Bustillo, Xabier Arana-Achaga, Jara Gayán Ordás, Jesús Piqueras-Flores, María Ruiz-Cueto, Carlos Casasnovas, Coloma Tirón, Ricard Rojas-García, Teresa Sevilla, José Fernando Rodríguez-Palomares, Esther González-López, Eduardo Villacorta, Pablo García-Pavía, José González-Costello

  Rev Esp Cardiol. 2025;78:768-77

• Impact of early SGLT2 inhibitors prescription on acute decompensated heart failure outcomes: insights from a real-world setting

  Luis E. Echeverría, Lyda Z. Rojas, Angie Yarlady Serrano-García, Daniel R. Botero, María Cantillo-Reines, Adriana M. Jurado, Karen Andrea García-Rueda, Ángela Torres-Bustamante, Diana Ivonne Cañón-Gómez, Carolina Idrovo-Turbay, Robinson Sánchez-García, Jaime Alberto Rodríguez, Sergio A. Gómez-Ochoa

  Rev Esp Cardiol. 2025;78:780-8

• Efficacy and safety of SGLT2 inhibitors in patients with heart failure according to kidney function: a systematic review and meta-analysis

  David Hong, Minseok Hong, Onyou Kim, Heayoung Shin, Minjung Bak, Darae Kim, Jihoon Kim, Ki Hong Choi, Eun Kyoung Kim, Joo Myung Lee, Jeong Hoon Yang, Sung-A. Chang, Sung-Ji Park, Sang-Chol Lee, Seung Woo Park, Jin-Oh Choi

  Rev Esp Cardiol. 2025;78:789-99

• Impact of left ventricular unloading on postheart transplantation outcomes in patients bridged with VA-ECMO

  Daniel Enríquez-Vázquez, Eduardo Barge-Caballero, Francisco González-Vílchez, Luis Almenar-Bonet, María Dolores García-Cosío Carmena, José González-Costello, Manuel Gómez-Bueno, María Ángeles Castel-Lavilla, Beatriz Díaz-Molina, Manuel Martínez-Sellés, Sonia Mirabet-Pérez, Luis de la Fuente-Galán, Daniela Hervás-Sotomayor, Diego Rangel-Sousa, Iris P. Garrido-Bravo, Teresa Blasco-Peiró, Gregorio Rábago Juan-Aracil, Javier Muñiz, María G. Crespo-Leiro

  Rev Esp Cardiol. 2025;78:494-503

• Prevalence of transthyretin cardiac amyloidosis in patients with heart failure with preserved ejection fraction: the PRACTICA study

  Pablo García-Pavía, José Manuel García-Pinilla, Ainara Lozano-Bahamonde, Sergi Yun, Antonio García-Quintana, Juan José Gavira-Gómez, Miguel Ángel Aibar-Arregui, Gonzalo Barge-Caballero, Julio Núñez Villota, Laura Bernal, Patricia Tarilonte

  Rev Esp Cardiol. 2025;78:301-10

• Early unloading and clinical outcomes in patients with fulminant myocarditis undergoing VA-ECMO: results of a multicenter retrospective study

  Minjung Bak, Junho Hyun, Hyukjin Park, Hyung Yoon Kim, Seonhwa Lee, In-Cheol Kim, So Ree Kim, Mi-Na Kim, Kyung-Hee Kim, Jeong Hoon Yang

  Rev Esp Cardiol. 2025;78:176-84

• Role of spot urinary sodium in outpatients with heart failure

  Miguel Lorenzo, Rafael de la Espriella, Gema Miñana, Gonzalo Núñez, Arturo Carratalá, Enrique Rodríguez, Enrique Santas, Neus Valls, Sandra Villar, Víctor Donoso, Antoni Bayés-Genís, Juan Sanchis, Julio Núñez

  Rev Esp Cardiol. 2025;78:185-95

• Impact of natriuresis on worsening renal function during episodes of acute heart failure

  Pedro Caravaca Pérez, Ignacio Fernández-Herrero, José Jesús Broseta, Nikein Ibarra-Márquez, Zorba Blázquez-Bermejo, Juan Carlos López-Azor, César Del Castillo Gordillo, Marta Cobo Marcos, Javier de Juan Bagudá, María Dolores García Cosío, Ana García-Álvarez, Marta Farrero, Juan F. Delgado

  Rev Esp Cardiol. 2025;78:196-205

• Pregnancy in women with dilated cardiomyopathy genetic variants

  María Alejandra Restrepo-Córdoba, Przemyslaw Chmielewski, Grażyna Truszkowska, María Luisa Peña-Peña, Miloš Kubánek, Alice Krebsová, Luis R. Lopes, Álvaro García-Ropero, Marco Merlo, Alessia Paldino, Stacey Peters, Ruxandra Jurcut, Roberto Barriales-Villa, Esther Zorio, Mark Hazebroek, Jens Mogensen, Pablo García-Pavía

  Rev Esp Cardiol. 2025;78:2-9

• Outcomes of patients with heart failure followed in units accredited by the SEC-Excelente-IC quality program according to the type of unit

  María Anguita Gámez, Juan L. Bonilla Palomas, Alejandro Recio Mayoral, Rafael González Manzanares, Javier Muñiz García, Nieves Romero Rodríguez, Francisco J. Elola Somoza, Ángel Cequier Fillat, Luis Rodríguez Padial, Manuel Anguita Sánchez

  Rev Esp Cardiol. 2025;78:12-21

• Clinical impact of remote heart failure management using the multiparameter ICD HeartLogic alert

  Javier de Juan Bagudá, Rocío Cózar León, Juan J. Gavira Gómez, Marta Pachón, Josebe Goirigolzarri Artaza, Virgilio Martínez Mateo, Vanessa Escolar Pérez, Ángel Manuel Iniesta Manjavacas, Nuria Rivas Gándara, Jesús Álvarez-García, Jesús Gabriel Sánchez Ramos, Cristina Aguilera Agudo, José Manuel Rubín López, Alfonso Macías Gallego, Silvia López Fernández, Luis González Torres, Juan Gabriel Martínez, Natalia Marrero Negrín, Javier Ramos Maqueda, Mercedes Cabrera Ramos, José María Medina Gil, Carlos De Diego Rus, Francisco José Bermúdez Jiménez, Inés Madrazo, Beatriz Díaz Molina, Marta Cobo Marcos, Ana Delia Ruiz Duthil, David Cordero, Ana Belén Méndez Fernández, Laura Peña Conde, María F. Arcocha Torres, Nicasio Pérez Castellano, Miguel Á. Arias, Ignacio García Bolao, Ernesto Díaz Infante, Monica Campari, Fernando Arribas Ynsaurriaga, Juan F. Delgado Jiménez, Sergio Valsecchi, Rafael Salguero Bodes

  Rev Esp Cardiol. 2024;77:1008-17

• Usefulness of biomarkers to predict prognosis after heart transplant

  Raquel López-Vilella, Julia Martínez Solé, Sara Huélamo Montoro, Víctor Donoso Trenado, Ignacio Sánchez-Lázaro, Iratxe Zarragoikoetxea Jauregui, Paula Carmona García, Manuel Pérez Guillén, Carlos Domínguez Massa, Luis Martínez Dolz, Luis Almenar Bonet

  Rev Esp Cardiol. 2024;77:1018-25

• A systematic review and meta-analysis of mortality in chronic Chagas cardiomyopathy versus other cardiomyopathies: higher risk or fiction?

  Sergio A. Gómez-Ochoa, Angie Yarlady Serrano-García, Alexandra Hurtado-Ortiz, Andrea Aceros, Lyda Z. Rojas, Luis E. Echeverría

  Rev Esp Cardiol. 2024;77:843-50

• Withdrawal of drug therapy in responders to cardiac resynchronization therapy: rationale and design of the REMOVE trial

  Francisco J. Pastor-Pérez, Iris P. Garrido-Bravo, Pablo Peñafiel-Verdú, Noelia Fernández-Villa, Sergio Manzano-Fernández, María José Oliva-Sandoval, María Teresa Pérez-Martínez, César Caro-Martínez, Álvaro Hernández-Vicente, Domingo A. Pascual-Figal, on behalf of the clinical trial REMOVE researches

  Rev Esp Cardiol. 2024;77:851-8

• Incidence and prediction of hospitalization for heart failure in patients with atrial fibrillation: the REFLEJA scale

  Javier Torres Llergo, Magdalena Carrillo Bailén, José María Segura Aumente, María Rosa Fernández Olmo, Miguel Puentes Chiachío, Juan Carlos Fernández Guerrero, Martín Ruiz Ortiz

  Rev Esp Cardiol. 2024;77:710-9